Edesa Biotech Stock Forecast - Simple Exponential Smoothing
| EDSA Stock | USD 1.34 0.04 2.90% |
Edesa Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Edesa Biotech stock prices and determine the direction of Edesa Biotech's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Edesa Biotech's historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, the RSI of Edesa Biotech's share price is approaching 37 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Edesa Biotech, making its price go up or down. Momentum 37
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.30) | EPS Estimate Current Year (1.79) | EPS Estimate Next Year (1.84) | Wall Street Target Price 11 | EPS Estimate Current Quarter (0.27) |
Using Edesa Biotech hype-based prediction, you can estimate the value of Edesa Biotech from the perspective of Edesa Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Exponential Smoothing forecasted value of Edesa Biotech on the next trading day is expected to be 1.34 with a mean absolute deviation of 0.04 and the sum of the absolute errors of 2.34. Edesa Biotech after-hype prediction price | USD 1.34 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Edesa Biotech to cross-verify your projections. Edesa Biotech Additional Predictive Modules
Most predictive techniques to examine Edesa price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Edesa using various technical indicators. When you analyze Edesa charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Edesa Biotech Simple Exponential Smoothing Price Forecast For the 30th of January
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Edesa Biotech on the next trading day is expected to be 1.34 with a mean absolute deviation of 0.04, mean absolute percentage error of 0, and the sum of the absolute errors of 2.34.Please note that although there have been many attempts to predict Edesa Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Edesa Biotech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Edesa Biotech Stock Forecast Pattern
| Backtest Edesa Biotech | Edesa Biotech Price Prediction | Buy or Sell Advice |
Edesa Biotech Forecasted Value
In the context of forecasting Edesa Biotech's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Edesa Biotech's downside and upside margins for the forecasting period are 0.01 and 4.91, respectively. We have considered Edesa Biotech's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Edesa Biotech stock data series using in forecasting. Note that when a statistical model is used to represent Edesa Biotech stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 110.5688 |
| Bias | Arithmetic mean of the errors | 0.0087 |
| MAD | Mean absolute deviation | 0.039 |
| MAPE | Mean absolute percentage error | 0.0252 |
| SAE | Sum of the absolute errors | 2.34 |
Predictive Modules for Edesa Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Edesa Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Edesa Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Edesa Biotech After-Hype Price Density Analysis
As far as predicting the price of Edesa Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Edesa Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Edesa Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Edesa Biotech Estimiated After-Hype Price Volatility
In the context of predicting Edesa Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Edesa Biotech's historical news coverage. Edesa Biotech's after-hype downside and upside margins for the prediction period are 0.07 and 4.91, respectively. We have considered Edesa Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Edesa Biotech is relatively risky at this time. Analysis and calculation of next after-hype price of Edesa Biotech is based on 3 months time horizon.
Edesa Biotech Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Edesa Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Edesa Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Edesa Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.47 | 3.57 | 0.00 | 0.01 | 9 Events / Month | 6 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.34 | 1.34 | 0.00 |
|
Edesa Biotech Hype Timeline
Edesa Biotech is currently traded for 1.34. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. Edesa is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at -0.47%. %. The volatility of related hype on Edesa Biotech is about 12310.34%, with the expected price after the next announcement by competition of 1.35. About 17.0% of the company shares are held by company insiders. The book value of Edesa Biotech was currently reported as 0.45. The company recorded a loss per share of 1.27. Edesa Biotech last dividend was issued on the 10th of June 2019. The entity had 1:7 split on the 11th of October 2023. Given the investment horizon of 90 days the next projected press release will be in about 9 days. Check out Historical Fundamental Analysis of Edesa Biotech to cross-verify your projections.Edesa Biotech Related Hype Analysis
Having access to credible news sources related to Edesa Biotech's direct competition is more important than ever and may enhance your ability to predict Edesa Biotech's future price movements. Getting to know how Edesa Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Edesa Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BRTX | BioRestorative Therapies | 0.03 | 8 per month | 0.00 | (0.1) | 6.36 | (5.93) | 37.70 | |
| DWTX | Dogwood Therapeutics | 0.42 | 7 per month | 0.00 | (0.12) | 7.78 | (11.30) | 33.43 | |
| COCP | Cocrystal Pharma | 0.02 | 9 per month | 3.00 | (0.02) | 7.45 | (6.36) | 18.39 | |
| OSRH | OSR Holdings | 0.01 | 7 per month | 6.27 | 0.02 | 16.07 | (10.14) | 43.23 | |
| TRAW | Traws Pharma | (0.06) | 12 per month | 8.51 | 0.03 | 17.70 | (12.77) | 58.96 | |
| IMRN | Immuron Ltd ADR | (0.06) | 5 per month | 0.00 | (0.16) | 5.88 | (12.72) | 36.62 | |
| ERNA | Eterna Therapeutics | (0.06) | 6 per month | 4.63 | 0.03 | 12.10 | (7.41) | 51.97 | |
| EVGN | Evogene | 0.01 | 7 per month | 0.00 | (0.07) | 3.77 | (5.22) | 21.65 | |
| SNSE | Sensei Biotherapeutics | 0.11 | 7 per month | 5.90 | 0.01 | 17.33 | (10.69) | 36.61 | |
| IMNN | Imunon Inc | (0.13) | 9 per month | 0.00 | (0.13) | 6.74 | (6.59) | 20.17 |
Other Forecasting Options for Edesa Biotech
For every potential investor in Edesa, whether a beginner or expert, Edesa Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Edesa Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Edesa. Basic forecasting techniques help filter out the noise by identifying Edesa Biotech's price trends.Edesa Biotech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Edesa Biotech stock to make a market-neutral strategy. Peer analysis of Edesa Biotech could also be used in its relative valuation, which is a method of valuing Edesa Biotech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Edesa Biotech Market Strength Events
Market strength indicators help investors to evaluate how Edesa Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Edesa Biotech shares will generate the highest return on investment. By undertsting and applying Edesa Biotech stock market strength indicators, traders can identify Edesa Biotech entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 1.34 | |||
| Day Typical Price | 1.34 | |||
| Price Action Indicator | (0.02) | |||
| Period Momentum Indicator | (0.04) | |||
| Relative Strength Index | 37.36 |
Edesa Biotech Risk Indicators
The analysis of Edesa Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Edesa Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting edesa stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.78 | |||
| Standard Deviation | 4.24 | |||
| Variance | 18.0 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Edesa Biotech
The number of cover stories for Edesa Biotech depends on current market conditions and Edesa Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Edesa Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Edesa Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Edesa Biotech Short Properties
Edesa Biotech's future price predictability will typically decrease when Edesa Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Edesa Biotech often depends not only on the future outlook of the potential Edesa Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Edesa Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.7 M | |
| Cash And Short Term Investments | 10.8 M |
Check out Historical Fundamental Analysis of Edesa Biotech to cross-verify your projections. For information on how to trade Edesa Stock refer to our How to Trade Edesa Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edesa Biotech. Projected growth potential of Edesa fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Edesa Biotech assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Edesa Biotech using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Edesa Biotech's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Edesa Biotech's market price to deviate significantly from intrinsic value.
It's important to distinguish between Edesa Biotech's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Edesa Biotech should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Edesa Biotech's market price signifies the transaction level at which participants voluntarily complete trades.